Freestone Grove Partners LP Makes New $24.54 Million Investment in Church & Dwight Co., Inc. (NYSE:CHD)

Freestone Grove Partners LP acquired a new stake in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 234,403 shares of the company's stock, valued at approximately $24,544,000. Freestone Grove Partners LP owned about 0.10% of Church & Dwight at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CHD. YANKCOM Partnership acquired a new stake in Church & Dwight during the 4th quarter valued at approximately $25,000. Versant Capital Management Inc grew its position in shares of Church & Dwight by 224.4% during the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company's stock worth $28,000 after buying an additional 184 shares in the last quarter. Strategic Financial Concepts LLC acquired a new stake in shares of Church & Dwight during the fourth quarter worth approximately $39,000. Bernard Wealth Management Corp. bought a new stake in shares of Church & Dwight in the fourth quarter worth $40,000. Finally, Bank of Jackson Hole Trust acquired a new stake in Church & Dwight in the fourth quarter valued at $43,000. 86.60% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $115.98, for a total value of $6,322,069.80. Following the completion of the sale, the executive vice president now directly owns 10,497 shares in the company, valued at $1,217,442.06. This represents a 83.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Rene Hemsey sold 11,060 shares of Church & Dwight stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now owns 6,437 shares in the company, valued at approximately $707,941.26. This trade represents a 63.21 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 65,570 shares of company stock valued at $7,538,449. Company insiders own 2.00% of the company's stock.

Church & Dwight Stock Performance

Shares of NYSE:CHD traded down $0.17 during trading hours on Monday, hitting $92.77. The stock had a trading volume of 1,976,925 shares, compared to its average volume of 1,578,114. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The stock's fifty day simple moving average is $105.85 and its 200 day simple moving average is $105.93. The firm has a market capitalization of $22.83 billion, a price-to-earnings ratio of 39.14, a PEG ratio of 3.32 and a beta of 0.55. Church & Dwight Co., Inc. has a 1-year low of $91.77 and a 1-year high of $116.46.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. The firm had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the previous year, the business earned $0.96 EPS. The firm's revenue for the quarter was down 2.4% on a year-over-year basis. Sell-side analysts anticipate that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Thursday, May 15th will be paid a $0.295 dividend. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date of this dividend is Thursday, May 15th. Church & Dwight's dividend payout ratio is currently 49.79%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CHD shares. Truist Financial raised their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Monday, February 3rd. Barclays lowered their price objective on Church & Dwight from $94.00 to $84.00 and set an "underweight" rating for the company in a report on Friday. Stifel Nicolaus increased their target price on Church & Dwight from $103.00 to $105.00 and gave the stock a "hold" rating in a report on Monday, February 3rd. Evercore ISI lowered their price target on Church & Dwight from $106.00 to $102.00 and set an "in-line" rating for the company in a report on Friday. Finally, Bank of America raised shares of Church & Dwight from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $112.00 to $125.00 in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $110.19.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.